Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSCORT
NCT05716607Withdrawn
- Sponsor
- Region Västra Götaland
- Start
- Jan 2025
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of hydrocortisone in Addison's disease (2 arms), sponsored by Region Västra Götaland. Primary endpoint: Glycemic variability at 4 weeks. Planned start Jan 2025; status: withdrawn.
02
Drugs
hydrocortisone
03
Conditions
Addison's disease
Beyond the preview
Go deeper on NCT05716607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05716607.